| Literature DB >> 28486498 |
Gregory Karadjian1, Frédéric Fercoq1, Nicolas Pionnier1, Nathaly Vallarino-Lhermitte1, Emilie Lefoulon1, Adélaïde Nieguitsila1, Sabine Specht2, Leo M Carlin3, Coralie Martin1.
Abstract
Filarial infections are tropical diseases caused by nematodes of the Onchocercidae family such as Mansonella perstans. The infective larvae (L3) are transmitted into the skin of vertebrate hosts by blood-feeding vectors. Many filarial species settle in the serous cavities including M. perstans in humans and L. sigmodontis, a well-established model of filariasis in mice. L. sigmodontis L3 migrate to the pleural cavity where they moult into L4 around day 9 and into male and female adult worms around day 30. Little is known of the early phase of the parasite life cycle, after the L3 is inoculated in the dermis by the vector and enters the afferent lymphatic vessels and before the moulting processes in the pleural cavity. Here we reveal a pulmonary phase associated with lung damage characterized by haemorrhages and granulomas suggesting L3 reach the lung via pulmonary capillaries and damage the endothelium and parenchyma by crossing them to enter the pleural cavity. This study also provides evidence for a transient inflammation in the lung characterized by a very early recruitment of neutrophils associated with high expression levels of S100A8 and S100A9 proteins.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28486498 PMCID: PMC5438187 DOI: 10.1371/journal.pntd.0005596
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Filarial nematodes with evidences of a pulmonary location.
| Subfamilly | Parasite | Host (experimental/accidental) | Described stage | Pulmonary location | Ref |
|---|---|---|---|---|---|
| Crocodylidae | Adults | Whole lungs | [ | ||
| Agamidae, (Agamidae) | Adults | Whole lungs | [ | ||
| Agamidae | Adults | Whole lungs | [ | ||
| Varanidae | Adults | Whole lungs | [ | ||
| Varanidae | Adults | Whole lungs | [ | ||
| Canidae | Adults, mf | Pulmonary arteries, bronchus | [ | ||
| (Humans) | Adults | Whole lungs | [ | ||
| Mustelidae | Adults | Pulmonary arteries | [ | ||
| Ranidae | Adults | Lung tissue | [ | ||
| Phocidae | Adults | Pulmonary arteries, Whole lungs | [ | ||
| nd, (Rodents) | L3, L4 | Whole lungs | [ | ||
| nd, (Rodents) | L3, L4, Adults | Whole lungs, pulmonary arteries | [ | ||
| Humans | mf | Whole lungs | [ | ||
| (Rodents) | L4, Adults, mf | Whole lungs, pulmonary arteries | [ | ||
| Leporidae | Adults | Pulmonary arteries | [ | ||
| Cuculidae | Adults | Whole lungs | [ | ||
| Camelidae | Adults | Pulmonary arteries | [ | ||
| nd, (Rodents) | L4, Adults | Whole lungs, pulmonary arteries | [ | ||
| nd, (Rodents) | L3, L4, Adults | Pulmonary arteries | [ | ||
| Psittacopasserae, Galloanserae | Adults | Pulmonary arteries | [ | ||
| Corvidae, Certhidae, Muscicapidae | Adults | Whole lungs | [ | ||
| Corvidae | Adults | Whole lungs and trachea | [ | ||
| Muridae | Adults | Pulmonary arteries | [ | ||
| Bovidae | Adults | Pulmonary arteries | [ | ||
| Ciconidae | Adults | Pulmonary arteries | [ | ||
| Phasianidae | Adults | Pulmonary arteries | [ | ||
| Phasianidae | Adults | Whole lungs, air sacs | [ | ||
| Phasianidae | Adults | Whole lungs | [ | ||
| Scolopacidae | Adults | Whole lungs | [ | ||
| Struthionidae | Adults | Whole lungs | [ | ||
| Phasianidae | Adults | Whole lungs | [ | ||
| Hirundinidae | Adults | Pulmonary arteries | [ | ||
| Corvidae | Adults | Pulmonary arteries (wall) | [ | ||
| Falconidae | Adults | Whole lungs | [ | ||
| Tyrannidae | Adults | Pulmonary arteries (wall) | [ | ||
| Equidae, Bovidae, Camelidae | Adults | Whole lungs | [ | ||
| Bovidae, Cervidae | Adults | Whole lungs | [ |
First column indicates the filarial subfamily and second column the filarial species. Natural hosts are presented in columns 3 and experimental/accidental hosts are indicated in parenthesis. The filarial stage described in the lung is indicated in column 5; details on the pulmonary location are given in column 6. nd = not described in lungs.
Fig 1L3 presence and loads in the lung and in the pleural cavity.
BALB/c mice were inoculated with 40 L3 of L. sigmodontis either subcutaneously (SC) or intravenously (IV) or L3 were transmitted through the bite of the vector mite O. bacoti (“natural infection”). (A-C) L. sigmodontis recovery rate (F/L3) on hour 2 (h2), hour 6 (h6), day 4 (d4) and day 8 (d8), once L3 were recovered either in the mechanically disrupted lungs or in the pleural cavity and counted. (A) Recovery rate in the lung (grey bars) and pleural cavity (white bars) of naturally infected mice (n = 8 per time point, pool of 2 independant experiments) (B) Recovery rate in the lung and pleural cavity of SC infected mice. (h2: n = 8, pool of 2 independent experiments); h6-d4-d8: n = 19–24, pool of 5 independent experiments; d6: n = 7). (C) Recovery rate in the lung and pleural cavity of IV infected mice. h2-h6, n = 8–12 (pool of 2 independent experiments); d4-d8, n = 6–8 (lung, pool of 2 independent experiments), n = 24 (pleural, pool of 5 independent experiments). (d) Haematoxylin-Eosin staining of lung sections at 6 hours post inoculation showing one L3 in lung tissue (white dotted circle). Bars represent the mean ± SEM.
Fig 2Hemorrhages in the lung of infected mice.
BALB/c mice were inoculated with 40 L3 of L. sigmodontis either subcutaneously (SC) or intravenously (IV). Representative picture of (A) a normal lung, (B) a lung with superficial numerous roundish well-delineated red hemorrhages. (C) Number of superficial pulmonary hemorrhages in lungs at six hours (h6), four days (d4) and eight days (d8) post inoculation. n = 6, bars represent the mean ± SEM; two-way ANOVA followed by Bonferonni, *** = p<0.001 (difference between IV- and SC-infected mice), ## = p<0.01(difference between timepoints in IV-infected mice). (D) Correlation test (Pearson) between the number of L3 recovered in the lung and the number of hemorrhages, r2 = 0.9148.
Fig 3Granulomas and neutrophil-infiltrated peri-vascular space in the lung of infected mice.
BALB/c mice were inoculated with 40 L3 of L. sigmodontis either subcutaneously (SC) or intravenously (IV). After two hours (h2) six hours (h6), two days (d2), four days (d4) and 8 days (d8) post inoculation, lung sections were prepared. (A) Haematoxylin-Eosin staining of a naïve lung section showing normal parenchyma and mesothelium. (B) Haematoxylin-Eosin staining of a lung section showing a granuloma in SC-infected mice at d8 p.i. (C) Ly6G/C (clone NIMPR-R14) immunostaining of lung sections at d8 p.i. (from a SC-infected mouse) were performed showing absence of neutrophils within the granuloma but presence in the surrounding tissue. Neutrophils were differentiated from monocytes by their nuclei shapes (cf corner zoom) (D) Representative maximum intensity projection from a confocal z-stack of S100A9 (an abundant neutrophil protein, magenta) immunostaining of lung precision cut lung slices (PCLS) at d8 p.i. (IV-infected mouse) showing absence of neutrophils within the granuloma but presence in the surrounding tissue; CD31 (green) stain for endothelial cells and histone H3 (red) for cells. (E-F) Representative maximum intensity projection from a confocal z-stack of a lung PCLS with CD31+ capillaries (red) surrounding larger airways (LA) and a peri-vascular space (PVS) (the boundaries of which are marked by dashed line) containing a blood vessel (BV) and a lymphatic vessel (*) with (E) the absence of Ly6G+ (clone 1A8) neutrophils (green) in the PVS of naïve mouse; and (F) the presence of Ly6G+ neutrophilic infiltrates in the PVS and around airways in a d4 IV-infected mouse.
Fig 4Quantification of macrophages, eosinophils and neutrophils in the bronchoalveolar and pleural spaces.
Flow cytometry phenotypic analyses of Ly6G neutrophils (clone 1A8), F4/80 macrophages (clone BM8) and Siglec F eosinophils (clone E50-2440) were performed at different time points (h2, h6, d4 and d8) post inoculation on pleural cells (PleC) or cells isolated from broncho-alveolar lavage (BAL) from IV- and SC-infected mice. (A-B) Number (nb) of F4/80+ macrophages in the broncho-alveolar lavage (A) and in the pleural cells (B); (C-D) Number of Siglec F+ eosinophils in broncho-alveolar lavage (C) and in the pleural cells (D);.(E-F) Number of Ly6G+ neutrophils in the broncho-alveolar lavage (E) and in the pleural cells (F). Number of cells in uninfected mice are represented by a dashed horizontal bar. The results are expressed as mean ± SEM, n = 4–6, Kruskal-Wallis followed by a Dunns (*p<0.05. **p<0.01, ***p<0.001 between infected and naive mice, #p<0.05 difference between SC- and IV-infected mice for a given time point).
Fig 5Transient early increase of S100A9 expressing neutrophils in the lung of infected mice.
BALB/c mice were inoculated with 40 L3 of L. sigmodontis either subcutaneously (SC) or intravenously (IV). Lung sections were analysed six hours (h6), four days (d4) and 8 days (d8) post inoculation. (A) Ly6G/C (clone NIMPR-R14) immunostaining of lung sections were performed showing a few interstitial neutrophils in naive mice (A) and an increase of neutrophils in h6-infected mice (B). Neutrophils were differentiated from monocytes by their nuclei shapes (B, corner zoom). (C) Number of neutrophils per mm2 on Ly6G/C immunostained sections; bars represent mean ± SEM, n = 4–6 (pool of 3 independent experiments), two-way ANOVA followed by a Bonferonni (**p<0.01, ***p<0.001). Uninfected mice are represented by a dashed horizontal bar. (D-G) S100A9 (clone MU14-2A5) immunostaining of lung sections were performed showing (D) low staining of S100A9 in neutrophils (black arrows). Alveolar macrophages (dotted arrows) are S100A9-. Top left corner: zoom on S100A9low neutrophil, (E) high staining of S100A9 in neutrophils. Top left corner: zoom on S100A9high neutrophil. (F) Total number of S100A9+ neutrophils and (G) number of S100A9high neutrophils per mm2 of lung. Uninfected mice are represented by a dashed horizontal bar. Results are expressed as mean ± SEM; n = 4 mice, 2–3 slides per mouse and 2–4 sections per slide were analyzed.
Fig 6Transient early increase of S100A9 in bronchoalveolar and pleural fluids and of s100a8 / s100a9 transcripts in lungs.
BALB/c mice were inoculated with 40 L3 L. sigmodontis either subcutaneously (SC) or intravenously (IV). Two hours (h2), six hours (h6), four days (d4) and 8 days (d8) post inoculation, mice were sacrificed. Bronchoalveolar and pleural lavages were performed then lungs were isolated and frozen. (A—D) Bronchoalveolar fluid (BAL) (A & B, respectively SC and IV infected mice; n = 6) and pleural fluid (PL) (C & D, respectively SC and IV infected mice; n = 10–12, pool of 3 independent experiments) were tested for S100A9 by ELISA. The results are expressed as mean ± SEM. One way ANOVA followed by a Bonferonni, ** = p<0.01, * = p<0.05 (difference between infected and naïve mice). nt: not tested. (E-F) A q-RTPCR was performed for (E) s100a8 and (F) s100a9 transcripts. Normalization was made with β-actin housekeeping gene by 2-ΔΔCT method, n = 5–6 (pool of 3 independent experiments). The results are expressed as fold-change mean ± SEM; a two-way ANOVA followed by a Bonferonni was performed, *p<0.05 difference between IV-and SC- infected mice, ##p<0.01, ###p<0.001 difference between timepoints.
Fig 7Inflammation and regulation.
Dosage of IL-1β (A) and IL-33 (B) in the pleural fluid (PL) by ELISA, n = 4–8 (pool of 2 independent experiments). Uninfected mice are represented by a dashed horizontal bar. (C) Cytokines/chemokines transcripts (cut-off: >2-fold change, FC) induced in the lung of SC-infected mice at d4 p.i and associated functions. The effects of the gene expression changes in the lung were predicted using Ingenuity Pathways Analysis (IPA); regulation of the functions is indicated by arrows. (D) A q-RTPCR was performed for Cxcl1 transcripts to validate the array results; n = 12 (SC) and 5 (IV). Dosage of IL-4 (D) and MCP-1 (E) in the broncho-alveolar lavage (BAL) by ELISA, n = 5–6. Uninfected mice are represented by a dashed horizontal bar. The results are expressed as mean ± SEM; a two-way ANOVA followed by a Bonferonni was performed for A, B, D and E, *p<0.05, **p<0.01, ***p<0.001 differences between infected mice and naive, ##p<0.01 difference between SC- and IV-infected mice at h6 for IL-1 β; a t-test was performed for Cxcl1, **p<0.01.
Cytokine overview.
| Cytokine | Injection | h6 | d4 | d8 | h6 | d4 | d8 |
|---|---|---|---|---|---|---|---|
| IL-1β | SC | 0 | 0 | 0 | = | = | |
| IV | 0 | 0 | 0 | = | = | ||
| IL-4 | SC | = | = | = | |||
| IV | = | = | = | ||||
| IL-6 | SC | 0 | 0 | 0 | 0 | 0 | 0 |
| IV | 0 | 0 | 0 | 0 | 0 | 0 | |
| IL-10 | SC | = | = | = | = | = | = |
| IV | = | = | = | = | = | = | |
| IL-17A | SC | = | = | = | = | = | = |
| IV | = | = | = | = | = | = | |
| IFN-γ | SC | = | = | = | = | = | = |
| IV | = | = | = | = | = | = | |
| MCP-1 | SC | = | = | = | |||
| IV | = | + | = | ||||
| TNF-α | SC | = | = | = | = | = | = |
| IV | = | = | = | = | = | = | |
| IL-33 | SC | 0 | 0 | 0 | = | = | |
| IV | 0 | 0 | 0 | = | = | ||
| CXCL1 | SC | = | = | = | = | ||
| IV | = | = | = | = |
BALB/c mice were inoculated with 40 L3 of L. sigmodontis either subcutaneously (SC) or intravenously (IV). Six hours (h6), four days (d4) and 8 days (d8) post inoculation, mice were sacrificed and broncho-alveolar and pleural washes were performed. ELISAs were realized in the broncho-alveolar fluid (BALF) and the pleural liquid (LP). First column indicates the tested cytokines. The second column gives the mode of L3 inoculation in mice (SC or IV). The third and fourth columns show the results for the BALF and the LP respectively. These two columns are subdivided in three sub-columns according to the considered time point (h6, d4 or d8). Scores were as follows: 0, no detection; =, detected but no difference between uninfected and infected groups; +, detection (from low + to high +++). n = 5–6 for BALF (pool of 2 to 3 independent experiments); n = 10–12 for LP (pool of 2 to 3 independent experiments).